phase 2
ii 1
study 2
belinostat 1
pxd 1
relapsed 2
refractory 2
aggressive 2
bcell 3
lymphomas 1
swog 2
s 2
ibritumomab 1
consolidation 1
cycles 1
chop 1
plus 1
radiotherapy 1
highrisk 1
limitedstage 1
lymphoma 2
imexon 1
prooxidant 1
molecule 1
nonhodgkin 1
